Funding Details
- Awarder
- RSS - theaiinsider.tech
- Date Award
- August 20, 2024
- Vertical
- Drug Discovery
- Funding URL
- View Funding Page
- Premoney Valuation
-
$8,500,000
- Valuation
-
$19,700,000
Company Info
- Founding Year
- 2020
- Traction
- Talus Bioscience has secured six non-dilutive grant awards exceeding $7.3M, along with $19.7M in venture funding to date.
- Founders
- Alex Federation, PhD, Lindsay Pino, PhD
- Company Description
- Talus Bio is a drug discovery biotech company that develops drugs targeting undruggable transcription factors using AI.
- Market
- Cancer Therapeutics
- Location
-
Seattle,
WA,
US
- Coinvestors
- WRF Capital, NFX, YC Continuity Fund, Funders Club VC, BoxOne Ventures
Links